Search

Home Transactions

Activ Pharmaceuticals Group

Lead financial advisor and sole funding arranger for Activ Pharmaceuticals Group (“APG”) on its acquisition of Corvina Foods.

Background

Founded through the consolidation of three specialist entities - Australian Vitamin and Sports Nutrition Pty Ltd (AVS), Aus Cosmetics Pty Ltd (ACS), and Teradoran Pty Ltd trading as Activ Pharmaceuticals (APS) - Activ Pharmaceuticals Group Pty Ltd (APG) is a full-service contract manufacturer across the pharmaceutical, cosmeceutical, and nutraceutical sectors.

333 Capital was engaged by APG to help with its growth agenda and Corvina was identified as a strong and highly complementary business. Founded in 1978, Corvina is one of Australia’s leading manufacturers of nutritional and confectionery products. 
 

How we helped 

333 Capital worked closely with APG management to validate the investment rationale for the transaction and managed a complex acquisition process. 333 Capital’s role as lead advisor included:

  • Identifying and validating the strategic rationale for the proposed transaction with Corvina Foods. 

  • Advising on the submission of an NBIO, including the valuation, transaction terms and transaction process. 

  • Preparation of detailed buy-side financial and merger model and strategy papers presented to and used by the APG Board for decision making throughout the transaction process. 

  • Management of the transaction process including coordination of vendor and acquirer legal, financial and other advisors. 

  • Arranged transaction funding, which comprised a new credit facility with Roadnight Capital and involved: 
    • Negotiation of facility agreement and other financing documentation 
    • Preparation of information memorandum and cashflow forecast modelling
    • Assistance with management of completion deliverables, conditions precedents and drawdown.​

  • Driving the transaction process whilst minimising the burden on APG management and board. 

  • Negotiating a comprehensive suite of transaction documents.

Result: 

333 Capital drove a diligent and successful buy-side process, which resulted in APG successfully acquiring Corvina Foods. The partnership enhances APG’s ability to deliver end-to-end product development and manufacturing solutions across adjacent sectors, while strengthening its relationships with some of Australia’s most trusted health and wellness brands.  

The 333 Capital deal team was Jason Bignell, Fergus Calder and Finn Cole-Adams. The transaction further emphasises 333 Capital’s credentials as a trusted advisor with deep experience across the consumer products sectors, with other recent successful transactions including: 

  • Debt refinance and equity raise for ASX listed Retail Food Group; 

  • Lead advisor to Venture Growth Partners on their sale of Curtain Hardware to Hunter Douglas; and 

  • Lead advisor to InSkin Cosmedics on their growth investment from the Australian Business Growth Fund.




​